Stockreport

MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver Disease Therapy Through 2035 [Yahoo! Finance]

MetaVia Inc.  (MTVA) 
PDF CAMBRIDGE, Mass. March 12, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, to [Read more]